Risk factors for recurrence of hepatitis C after liver transplantation

Liver Transplantation and Surgery

Volumn 4, Issue 4, 1998, Pages 265-270

  Herrero, J I ^a   De La Pena, A ^a   Quiroga, J ^a   Sangro, B ^a   Garcia, N ^a   Sola, I ^a   Cienfuegos, J A ^a   P Civeira, M ^a   Prieto, J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT FAILURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 0031926666     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040406     Document Type: Article

References (22)

1. 1 Wright TL, Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transplant Surg 1995 ; 1: 30–42.
2. 2 Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995 ; 21: 30–34. MEDLINE
3. 3 Weinstein JS, Poterucha JJ, Rakela J, Krom RAF, Wiesner RH. Long‐term outcome of hepatitis C (HCV) infected liver transplant (OLT) recipients [abstract]. Hepatology 1994 ; 20: 133A.
4. 4 Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long‐term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996 ; 334: 815–820. MEDLINE
5. 5 Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992 ; 16: 865–876. MEDLINE
6. 6 Schluger LK, Sheiner PA, Thung SN, Lau JYN, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996 ; 23: 971–976. MEDLINE
7. 7 Shiffman ML, Contos MJ, Luketic VA, Sanyal AJ, Purdum PP, Mills AS, et al. Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation 1994 ; 57: 526–532. MEDLINE
8. 8 Henley KS, Lucey MR, Appelman HD, Baliga P, Brown KA, Burtch GD, et al. Biochemical and histopathological correlation in liver transplant: The first 180 days. Hepatology 1992 ; 16: 688–693. MEDLINE
9. 9 Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 ; 1: 431–435. MEDLINE
10. 10 Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994 ; 106: 994–999. MEDLINE
11. 11 Féray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994 ; 20: 1137–1143. MEDLINE
12. 12 Gretch DR, Bacchi C, Corey L, De la Rosa C, Lesniewski RR, Kowdley K, et al. Persistent infection after liver transplantation: Clinical and virological features. Hepatology 1995 ; 22: 1–9. MEDLINE
13. 13 Di Martino V, Féray C, Saurini F, Samuel D, Reynès M, Bismuth H. Relation between intra‐hepatic replication, genotypes and recurrent liver disease due to hepatitis C virus after liver transplantation [abstract]. J Hepatol 1995 ; 23 (suppl 1): 152.
14. 14 Herrero JI, Lasarte JJ, Quiroga J, Sangro B, Betés M, García N, et al. Quantification of liver HCV RNA in liver transplant recipients [abstract]. J Hepatol 1995 ; 23 (suppl 1): 153. MEDLINE
15. 15 Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995 ; 108: 1088–1096. MEDLINE
16. 16 Belli LS, Silini E, Alberti A, Bellati G, Fesce E, Gelosa F, et al. HCV genotypes, post transplant hepatitis (PTH) and HCV recurrence after liver transplantation [abstract]. Hepatology 1994 ; 20: 131A.
17. 17 Zhou S, Kim M, Ferrell L, Wright TL. HCV genotyping of liver transplant (OLT) recipients: Relation to viremia and histology [abstract]. Hepatology 1994 ; 20: 134A.
18. 18 Singh N, Gayowski T, Ndimbie OK, Nedjar S, Wagener MM, Yu VL. Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: Association with rejection and increased immunosuppression after transplantation. Surgery 1996 ; 119: 452–456. MEDLINE
19. 19 Gane EJ, Naoumov NV, Qian K‐P, Mondelli MU, Maertens G, Portmann BC, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996 ; 110: 167–177. MEDLINE
20. 20 Johnson MW, Washburn WK, Freeman RB, FitzMaurice SE, Dienstag J, Basgoz N, et al. Hepatitis C viral infection in liver transplantation. Arch Surg 1996 ; 131: 284–291. MEDLINE
21. 21 Farges O, Féray C, Samuel D, Krygier A, Sebagh M, Bismuth H. The level of immunosuppression does not appear to influence the natural history of recurrent disease in patients transplanted for HCV cirrhosis [abstract]. J Hepatol 1995 ; 23 (suppl 1): 84.
22. 22 González‐Peralta RP, Lau JYN. Pathogenesis of hepatocellular damage in chronic hepatitis C virus infection. Semin Gastrointest Dis 1995 ; 6: 28–34. MEDLINE